Loading in 2 Seconds...
Loading in 2 Seconds...
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Order this report by calling
+1 888 391 5441 or Send an email to email@example.com with your contact details and questions if any.
Fungal infection is most common in those with weakened immune system or those who have foreign material, including medical devices in their body like an artificial joint or heart valve. Fungal infections are categorized under opportunistic and primary fungal infection. Opportunistic fungal infection targets weak immune patients and can be very aggressive, spreading quickly to other organs and often leading to death. While primary fungal infection can occur in people with a normal immune system. There are several types of antifungal medicines. They come in as creams, sprays, solutions, tablets designed to go into the vagina (pessaries), shampoos, medicines to take by mouth, and injections. Most work by damaging the cell wall of the fungus, which causes the fungal cell to die.
The US is the largest market of anti-fungaldrugs. It has the presence of the leading companies who specialize in anti-fungal drugs. The key factors driving growth of the anti-fungal market include rise in incidences of fungal infections in immuno-compromised patients, increase in number of cancer patients, rise in incidences of fungal infections in people suffering from AIDS, increase in spending on medicines, rise in sale of prescription drugs and many more.
However, market growth is hindered by the factors such as harsh side effects of drugs, drug resistance, high cost of anti-fungal, and lack of new anti-fungal therapies. The major trends featuring the market include increase in development of new drugs, flourishing public-private partnership in pharmaceutical industry, and growing awareness.
Key Company Coverage: Johnson & Johnson, Novartis AG, Pfizer Inc. & Merck & Co. Inc.
The report offers an in-depth analysis of the “Global Anti-Fungal Market” with special focus on invasive anti-fungal segment. It covers the regional and global aspects of the market. The top notch players in the market exhibit a very close competition. The report profiles JNJ, Novartis, Pfizer, and Merck & Co.
Few Points from List of Tables Provided in Global Antifungal Market:
Risk Factors for Developing Fungal InfectionsGlobal Invasive Anti-Fungal Market by Therapeutic Indication (2015)Development Progress of Anti-Fungal DrugsGlobal Estimates of Fungal Infection in Immuno-Compromised Patients (2015)Global Estimates and Related Deaths of Fungal Infection per Year among People with AIDsHarsh Side Effects of Anti-Fungal DrugsHigh Cost of Anti-fungal DrugsMajor Product Comparison (2015)New Innovative Product Portfolio of Johnson & Johnson (2015)New Products of Pfizer with FDA Approval (2015/2016)FDA Approvals to Merck & Co. Products (2015/2016)
Explore more pharmaceuticals market research as well as other newly published reports by Koncept Analytics at http://www.marketreportsonline.com/publisher/koncept-analytics-market-research.html.
Global Thalassemia Market Report: 2016 Edition
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune, Maharashtra, India
Tel: + 1 888 391 5441